Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents
Clinical trial NCT01302847 · COMPLETED
Trial details
- NCT number
- NCT01302847
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-20
- Primary completion
- 2021-01-20
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.